Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where soggetti phrase all words 'V3 LOOP' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 384 riferimenti
Si mostrano 100 riferimenti a partire da 1
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Lemiale, F; Brand, D; Lebigot, S; Verrier, T; Buzelay, L; Brunet, S; Barin, F
      Immunogenicity of recombinant envelope glycoproteins derived from T-cell line-adapted isolates or primary HIV isolates - A comparative study using multivalent vaccine approaches

      JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
    2. Parry, JV; Murphy, G; Barlow, KL; Lewis, K; Rogers, PA; Belda, FJ; Nicoll, A; McGarrigle, C; Cliffe, S; Mortimer, PP; Clewley, JP
      National surveillance of HIV-1 subtypes for England and Wales - Design, methods, and initial findings

      JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
    3. Rodi, DJ; Agoston, GE; Manon, R; Lapcevich, R; Green, SJ; Makowski, L
      Identification of small molecule binding sites within proteins using phagedisplay technology

      COMBINATORIAL CHEMISTRY & HIGH THROUGHPUT SCREENING
    4. Ramsland, PA; Yuriev, E; Edmundson, AB
      Immunoglobulin cross-reactivity examined by library screening, crystallography and docking studies

      COMBINATORIAL CHEMISTRY & HIGH THROUGHPUT SCREENING
    5. Golding, B; Scott, DE; Scharf, O; Huang, LY; Zaitseva, M; Lapham, C; Eller, N; Golding, H
      Immunity and protection against Brucella abortus

      MICROBES AND INFECTION
    6. McDonald, RA; Chang, G; Michael, NL
      Relationship between V3 genotype, biologic phenotype, tropism, and coreceptor use for primary isolates of human immunodeficiency virus type 1

      JOURNAL OF HUMAN VIROLOGY
    7. Saha, K; Zhang, JC; Gupta, A; Dave, R; Yimen, M; Zerhouni, B
      Isolation of primary HIV-1 that target CD8(+) T Lymphocytes using CD8 as areceptor

      NATURE MEDICINE
    8. Cruz, LJ; Iglesias, E; Aguilar, JC; Quintana, D; Garay, HE; Duarte, C; Reyes, O
      Study of different coupling agents in the conjugation of a V3-based synthetic MAP to carrier proteins

      JOURNAL OF PEPTIDE SCIENCE
    9. Polzer, S; Dittmar, MT; Schmitz, H; Meyer, B; Muller, H; Krausslich, HG; Schreiber, M
      Loss of N-linked glycans in the V3-loop region of gp120 is correlated to an enhanced infectivity of HIV-1

      GLYCOBIOLOGY
    10. Doranz, BJ; Filion, LG; Diaz-Mitoma, F; Sitar, DS; Sahai, J; Baribaud, FD; Orsini, MJ; Benovic, JL; Cameron, W; Doms, RW
      Safe use of the CXCR4 inhibitor ALX40-4C in humans

      AIDS RESEARCH AND HUMAN RETROVIRUSES
    11. Bolmstedt, A; Hinkula, J; Rowcliffe, E; Biller, M; Wahren, B; Olofsson, S
      Enhanced immunogenicity of a human immunodeficiency virus type 1 env DNA vaccine by manipulating N-glycosylation signals - Effects of elimination of the V3N306 glycan

      VACCINE
    12. Toledo, H; Baly, A; Castro, O; Resik, S; Laferte, J; Rolo, F; Navea, L; Lobaina, L; Cruz, O; Miguez, J; Serrano, T; Sierra, B; Perez, L; Ricardo, ME; Dubed, M; Lubian, AL; Blanco, M; Millan, JC; Ortega, A; Iglesias, E; Penton, E; Martin, Z; Perez, J; Diaz, M; Duarte, CA
      A phase I clinical trial of a mufti-epitope polypeptide TAB9 combined withMontanide ISA 720 adjuvant in non-HIV-1 infected human volunteers

      VACCINE
    13. Chen, MS; Shi, CF; Kalia, V; Tencza, SB; Montelaro, RC; Gupta, P
      HIV gp120 V-1/V-2 andC(2)-V-3 domains glycoprotein compatibility is required for viral replication

      VIRUS RESEARCH
    14. Resch, W; Hoffman, N; Swanstrom, R
      Improved success of phenotype prediction of the human immunodeficiency virus type 1 from envelope variable loop 3 sequence using neural networks

      VIROLOGY
    15. Aarons, EJ; Beddows, S; Willingham, T; Wu, LJ; Koup, RA
      Adaptation to blockade of human immunodeficiency virus type 1 entry imposed by the anti-CCR5 monoclonal antibody 2D7

      VIROLOGY
    16. Zhang, KY; Hawken, M; Rana, F; Welte, FJ; Gartner, S; Goldsmith, MA; Power, C
      Human immunodeficiency virus type 1 clade A and D neurotropism: Molecular evolution, recombination, and coreceptor use

      VIROLOGY
    17. Callebaut, C; Nisole, S; Briand, JP; Krust, B; Hovanessian, AG
      Inhibition of HIV infection by the cytokine midkine

      VIROLOGY
    18. Cummins, JE; Bunn, WJ; Hall, SD; Donze, HH; Mestecky, J; Jackson, S
      In vitro exposure to highly cytopathic HIV-1 X4 strains increases expression of mucosa-associated integrins on CD4(+) T cells

      VIROLOGY
    19. Kolchinsky, P; Kiprilov, E; Bartley, P; Rubinstein, R; Sodroski, J
      Loss of a single N-linked glycan allows CD4-independent human immunodeficiency virus type 1 infection by altering the position of the gp120 V1/V2 variable loops

      JOURNAL OF VIROLOGY
    20. Spenlehauer, C; Kirn, A; Aubertin, AM; Moog, C
      Antibody-mediated neutralization of primary human immunodeficiency virus type 1 isolates: Investigation of the mechanism of inhibition

      JOURNAL OF VIROLOGY
    21. Hotzel, I; Cheevers, WP
      Conservation of human immunodeficiency virus type 1 gp120 inner-domain sequences in lentivirus and type A and B retrovirus envelope surface glycoproteins

      JOURNAL OF VIROLOGY
    22. Zwick, MB; Wang, M; Poignard, P; Stiegler, G; Katinger, H; Burton, DR; Parren, PWHI
      Neutralization synergy of human immunodeficiency virus type 1 primary isolates by cocktails of broadly neutralizing antibodies

      JOURNAL OF VIROLOGY
    23. Gorry, PR; Bristol, G; Zack, JA; Ritola, K; Swanstrom, R; Birch, CJ; Bell, JE; Bannert, N; Crawford, K; Wang, H; Schols, D; De Clercq, E; Kunstman, K; Wolinsky, SM; Gabuzda, D
      Macrophage tropism of human immunodeficiency virus type 1 isolates from brain and lymphoid tissues predicts neurotropism independent of coreceptor specificity

      JOURNAL OF VIROLOGY
    24. Derdeyn, CA; Decker, JM; Sfakianos, JN; Zhang, ZJ; O'Brien, WA; Ratner, L; Shaw, GM; Hunter, E
      Sensitivity of human immunodeficiency virus type 1 to fusion inhibitors targeted to the gp41 first heptad repeat involves distinct regions of gp41 and is consistently modulated by gp120 interactions with the coreceptor

      JOURNAL OF VIROLOGY
    25. Mbah, HA; Burda, S; Gorny, MK; Williams, C; Revesz, K; Zolla-Pazner, S; Nyambi, PN
      Effect of soluble CD4 on exposure of epitopes on primary, intact, native human immunodeficiency virus type I virions of different genetic clades

      JOURNAL OF VIROLOGY
    26. Tokunaga, K; Greenberg, ML; Morse, MA; Cumming, RI; Lyerly, HK; Cullen, BR
      Molecular basis for cell tropism of CXCR4-dependent human immunodeficiencyvirus type 1 isolates

      JOURNAL OF VIROLOGY
    27. Chen, CH; Jin, L; Zhu, CB; Holz-Smith, S; Matthews, TJ
      Induction and characterization of neutralizing antibodies against a human immunodeficiency virus type 1 primary isolate

      JOURNAL OF VIROLOGY
    28. Montefiori, DC; Safrit, JT; Lydy, SL; Barry, AP; Bilska, M; Vo, HTT; Klein, M; Tartaglia, J; Robinson, HL; Rovinski, B
      Induction of neutralizing antibodies and gag-specific cellular immune responses to an R5 primary isolate of human immunodeficiency virus type 1 in rhesus macaques

      JOURNAL OF VIROLOGY
    29. Cormier, EG; Tran, DNH; Yukhayeva, L; Olson, WC; Dragic, T
      Mapping the determinants of the CCRS amino-terminal sulfopeptide interaction with soluble human immunodeficiency virus type 1 gp120-CD4 complexes

      JOURNAL OF VIROLOGY
    30. Trouplin, V; Salvatori, F; Cappello, F; Obry, V; Brelot, A; Heveker, N; Alizon, M; Scarlatti, G; Clavel, F; Mammano, F
      Determination of coreceptor usage of human immunodeficiency virus type 1 from patient plasma samples by using a recombinant phenotypic assay

      JOURNAL OF VIROLOGY
    31. Dragic, T
      An overview of the determinants of CCR5 and CXCR4 co-receptor function

      JOURNAL OF GENERAL VIROLOGY
    32. Philpott, S; Weiser, B; Anastos, K; Kitchen, CMR; Robison, E; Meyer, WA; Sacks, HS; Mathur-Wagh, U; Brunner, C; Burger, H
      Preferential suppression of CXCR4-specific strains of HIV-1 by antiviral therapy

      JOURNAL OF CLINICAL INVESTIGATION
    33. Babcock, GJ; Mirzabekov, T; Wojtowicz, W; Sodroski, J
      Ligand binding characteristics of CXCR4 incorporated into paramagnetic proteoliposomes

      JOURNAL OF BIOLOGICAL CHEMISTRY
    34. Lauceri, R; Campagna, T; Raudino, A; Purrello, R
      Porphyrin binding and self-aggregation onto polymeric matrix: a combined spectroscopic and modelling approach

      INORGANICA CHIMICA ACTA
    35. Zaitseva, M; King, LR; Manischewitz, J; Dougan, M; Stevan, L; Golding, H; Golding, B
      Human peripheral blood T cells, monocytes, and macrophages secrete macrophage inflammatory proteins 1 alpha and 1 beta following stimulation with heat-inactivated Brucella abortus

      INFECTION AND IMMUNITY
    36. Vranken, WF; Fant, F; Budesinsky, M; Borremans, FAM
      Conformational model for the consensus V3 loop of the envelope protein gp120 of HIV-1 in a 20% trifluoroethanol/water solution

      EUROPEAN JOURNAL OF BIOCHEMISTRY
    37. Zeder-Lutz, G; Hoebeke, J; Van Regenmortel, MHV
      Differential recognition of epitopes present on monomeric and oligomeric forms of gp160 glycoprotein of human immunodeficiency virus type 1 by human monoclonal antibodies

      EUROPEAN JOURNAL OF BIOCHEMISTRY
    38. Hussein, M; Abebe, A; Pollakis, G; Brouwer, M; Petros, B; Fontanet, AL; de Wit, TFR
      HIV-1 subtype C in commercial sex workers in Addis Ababa, Ethiopia

      JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
    39. Casado, C; Urtasun, I; Martin-Walther, MV; Garcia, S; Rodriguez, C; del Romero, J; Lopez-Galindez, C
      Genetic analysis of HIV-1 samples from Spain

      JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
    40. Wizemann, H; Weiland, F; Pfaff, E; von Brunn, A
      Polyhistidine-tagged hepatitis B core particles as carriers of HIV-1/gp120epitopes of different HIV-1 subtypes

      BIOLOGICAL CHEMISTRY
    41. Carlier, E; Mabrouk, K; Moulard, M; Fajloun, Z; Rochat, H; De Waard, M; Sabatier, JM
      Ion channel activation by SPC3, a peptide derived from the HIV-1 gp120 V-3loop

      JOURNAL OF PEPTIDE RESEARCH
    42. Sobolev, BN; Poroikov, VV; Olenina, LV; Kolesanova, EF; Archakov, AI
      Comparative analysis of amino acid sequences from envelope proteins isolated from different hepatitis C virus variants: possible role of conservativeand variable regions

      JOURNAL OF VIRAL HEPATITIS
    43. Mansur, A; Chu, CM; Karnik, A; Frieri, M
      Nitric oxide production and apoptosis by GP120

      ALLERGY AND ASTHMA PROCEEDINGS
    44. Silvestris, F; Cocco, T; Cafforio, P; Calvani, N; Dammacco, F
      Immunogenicity of an eight amino acid domain by Fas (CD95/Apo-I) and HIV-1gp120. I. Structural and antigenic analysis

      MOLECULAR MEDICINE
    45. Cruz, LJ; Quintana, D; Iglesias, E; Garcia, Y; Huerta, V; Garay, HE; Duarte, C; Reyes, O
      Immunogenicity comparison of a multi-antigenic peptide bearing V3 sequences of the human immunodeficiency virus type 1 with TAB9 protein in mice

      JOURNAL OF PEPTIDE SCIENCE
    46. Tugarinov, V; Zvi, A; Levy, R; Hayek, Y; Matsushita, S; Anglister, J
      NMR structure of an anti-gp120 antibody complex with a V3 peptide reveals a surface important for co-receptor binding

      STRUCTURE WITH FOLDING & DESIGN
    47. Kwong, PD; Wyatt, R; Majeed, S; Robinson, J; Sweet, RW; Sodroski, J; Hendrickson, WA
      Structures of HIV-1 gp120 envelope glycoproteins from laboratory-adapted and primary isolates

      STRUCTURE
    48. Gemignani, A; Paudice, P; Pittaluga, A; Raiteri, M
      The HIV-1 coat protein gp120 and some of its fragments potently activate native cerebral NMDA receptors mediating neuropeptide release

      EUROPEAN JOURNAL OF NEUROSCIENCE
    49. Balbach, JJ; Yang, J; Weliky, DP; Steinbach, PJ; Tugarinov, V; Anglister, J; Tycko, R
      Probing hydrogen bonds in the antibody-bound HIV-1 gp120 V3 loop by solid state NMR REDOR measurements

      JOURNAL OF BIOMOLECULAR NMR
    50. Subbarao, S; Vanichseni, S; Hu, DJ; Kitayaporn, D; Choopanya, K; Raktham, S; Young, NL; Wasi, C; Sutthent, R; Luo, CC; Ramos, A; Mastro, TD
      Genetic characterization of incident HIV type 1 subtype E and B strains from a prospective cohort of injecting drug users in Bangkok, Thailand

      AIDS RESEARCH AND HUMAN RETROVIRUSES
    51. Lee, MK; Martin, MA; Cho, MW
      Higher Western blot immunoreactivity of glycoprotein 120 from R5 HIV type 1 isolates compared with X4 and X4R5 isolates

      AIDS RESEARCH AND HUMAN RETROVIRUSES
    52. Cabrera, C; Gutierrez, A; Blanco, J; Barretina, J; Litovchick, A; Lapidot, A; Evdokimov, AG; Clotet, B; Este, JA
      Anti-human immunodeficiency virus activity of novel aminoglycoside-arginine conjugates at early stages of infection

      AIDS RESEARCH AND HUMAN RETROVIRUSES
    53. Nisole, S; Krust, B; Dam, E; Bianco, A; Seddiki, N; Loaec, S; Callebaut, C; Guichard, G; Muller, S; Briand, JP; Hovanessian, AG
      The HB-19 pseudopeptide S[K psi(CH2N)PR]-TASP inhibits attachment of T lymphocyte- and macrophage-tropic HIV to permissive cells

      AIDS RESEARCH AND HUMAN RETROVIRUSES
    54. Bures, R; Gaitan, A; Zhu, TF; Graziosi, C; McGrath, KM; Tartaglia, J; Caudrelier, P; EL Habib, R; Klein, M; Lazzarin, A; Stablein, DM; Deers, M; Corey, L; Greenberg, ML; Schwartz, DH; Montefiori, DC
      Immunization with recombinant canarypox vectors expressing membrane-anchored glycoprotein 120 followed by glycoprotein 160 boosting fails to generateantibodies that neutralize R5 primary isolates of human immunodeficiency virus type 1

      AIDS RESEARCH AND HUMAN RETROVIRUSES
    55. Wang, WK; Lee, CN; Dudek, T; Chang, SY; Zhao, YJ; Essex, M; Lee, TH
      Interaction between HIV type 1 glycoprotein 120 and CXCR4 coreceptor involves a highly conserved arginine residue in hypervariable region 3

      AIDS RESEARCH AND HUMAN RETROVIRUSES
    56. Velarde-Dunois, KG; Guimaraes, ML; La Fuente, C; Andrade, R; Arevalo, R; Pantoja, S; Mariscal, R; Sandoval, R; Iriarte, F; Chamon, V; Melgar, ML; Carvajal, R; Morgado, MG
      Molecular characterization of human immunodeficiency virus type 1-infectedindividuals from Bolivia reveals the presence of two distinct genetic subtypes B and F

      AIDS RESEARCH AND HUMAN RETROVIRUSES
    57. Dejucq, N
      HIV-1 replication in CD4(+) T cell lines: the effects of adaptation on co-receptor use, tropism, and accessory gene function

      JOURNAL OF LEUKOCYTE BIOLOGY
    58. Tugarinov, V; Anglister, J
      Solution structure of an antibody-bound HIV-1(IIIB)V3 peptide: A cis proline turn linking two beta-hairpin strands

      JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS
    59. Lee, SK; Pestano, GA; Riley, J; Hasan, AS; Pezzano, M; Samms, M; Park, KJ; Guyden, J; Boto, WMO
      A single point mutation in HIV-1V3 loop alters the immunogenic properties of rgp120

      ARCHIVES OF VIROLOGY
    60. Wittekindt, B; Betz, H; Laube, B
      Subunit-dependent inhibition of recombinant rodent N-methyl-D-aspartate receptors by a HIV-1 glycoprotein 120 derived peptide

      NEUROSCIENCE LETTERS
    61. Wang, B; Spira, TJ; Owen, S; Lal, RB; Saksena, NK
      HIV-1 strains from a cohort of American subjects reveal the presence of a V2 region extension unique to slow progressors and non-progressors

      AIDS
    62. Boutet, A; Altmeyer, R; Hery, C; Tardieu, M
      Direct role of plasma membrane-expressed gp120/41 in toxicity to human astrocytes induced by HIV-1-infected macrophages

      AIDS
    63. Russell, KL; Carcamo, C; Watts, DM; Sanchez, J; Gotuzzo, E; Euler, A; Blanco, JC; Galeano, A; Alava, A; Mullins, JI; Holmes, KK; Carr, JK
      Emerging genetic diversity of HIV-1 in South America

      AIDS
    64. Ratnaparkhi, GS; Awasthi, SK; Rani, P; Balaram, P; Varadarajan, R
      Structural and thermodynamic consequences of introducing alpha-aminoisobutyric acid in the S peptide of ribonuclease S

      PROTEIN ENGINEERING
    65. McAllister, JJ; Phillips, D; Millhouse, S; Conner, J; Hogan, T; Ross, HL; Wigdahl, B
      Analysis of the HIV-1 LTR NF-kappa B-proximal Sp site III: Evidence for cell type-specific gene regulation and viral replication

      VIROLOGY
    66. Wang, B; Lal, RB; Dwyer, DE; Miranda-Saksena, M; Boadle, R; Cunningham, AL; Saksena, NK
      Molecular and biological interactions between two HIV-1 strains from a coinfected patient reveal the first evidence in favor of viral synergism

      VIROLOGY
    67. Brand, D; Lemiale, F; Thibault, G; Verrier, B; Lebigot, S; Roingeard, P; Buzelay, L; Brunet, S; Barin, F
      Antigenic properties of recombinant envelope glycoproteins derived from T-cell-line-adapted isolates or primary human immunodeficiency virus isolatesand their relationship to immunogenicity

      VIROLOGY
    68. Cormier, EG; Persuh, M; Thompson, DAD; Lin, SW; Sakmar, TP; Olson, WC; Dragic, T
      Specific interaction of CCR5 amino-terminal domain peptides containing sulfotyrosines with HIV-1 envelope glycoprotein gp120

      PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
    69. Moulard, M; Lortat-Jacob, H; Mondor, I; Roca, G; Wyatt, R; Sodroski, J; Lu, Z; Olson, W; Kwong, PD; Sattentau, QJ
      Selective interactions of polyanions with basic surfaces on human immunodeficiency virus type 1 gp120

      JOURNAL OF VIROLOGY
    70. Kwong, PD; Wyatt, R; Sattentau, QJ; Sodroski, J; Hendrickson, WA
      Oligomeric modeling and electrostatic analysis of the gp120 envelope glycoprotein of human immunodeficiency virus

      JOURNAL OF VIROLOGY
    71. Hu, QX; Barry, AP; Wang, ZX; Connolly, SM; Peiper, SC; Greenberg, ML
      Evolution of the human immunodeficiency virus type 1 envelope during infection reveals molecular corollaries of specificity for coreceptor utilization and AIDS pathogenesis

      JOURNAL OF VIROLOGY
    72. Nyambi, PN; Nadas, A; Mbah, HA; Burda, S; Williams, C; Gorny, MK; Zolla-Pazner, S
      Immunoreactivity of intact virions of human immunodeficiency virus type 1 (HIV-1) reveals the existence of fewer HIV-1 immunotypes than genotypes

      JOURNAL OF VIROLOGY
    73. Verrier, F; Burda, S; Belshe, R; Duliege, AM; Excler, JL; Klein, M; Zolla-Pazner, S
      A human immunodeficiency virus prime-boost immunization regimen in humans induces antibodies that show interclade cross-reactivity and neutralize several X4-, R5-, and dualtropic clade B and C primary isolates

      JOURNAL OF VIROLOGY
    74. Ly, A; Stamatatos, L
      V2 loop glycosylation of the human immunodeficiency virus type 1 SF162 envelope facilitates interaction of this protein with CD4 and CCRS receptors and protects the virus from neutralization by anti-V3 loop and anti-CD4 binding site antibodies

      JOURNAL OF VIROLOGY
    75. Nyambi, PN; Mbah, HA; Burda, S; Williams, C; Gorny, MK; Nadas, A; Zolla-Pazner, S
      Conserved and exposed epitopes on intact, native, primary human immunodeficiency virus type 1 virions of group M

      JOURNAL OF VIROLOGY
    76. Arthos, J; Rubbert, A; Rabin, RL; Cicala, C; Machado, E; Wildt, K; Hanbach, M; Steenbeke, TD; Swofford, R; Farber, JM; Fauci, AS
      CCR5 signal transduction in macrophages by human immunodeficiency virus and simian immunodeficiency virus envelopes

      JOURNAL OF VIROLOGY
    77. Liao, HX; Etemad-Moghadam, B; Montefiori, DC; Sun, Y; Sodroski, J; Scearce, RM; Doms, RW; Thomasch, JR; Robinson, S; Letvin, NL; Haynes, BF
      Induction of antibodies in guinea pigs and rhesus monkeys against the human immunodeficiency virus type 1 envelope: Neutralization of nonpathogenic and pathogenic primary isolate simian/human immunodeficiency virus strains

      JOURNAL OF VIROLOGY
    78. Moja, P; Tranchat, C; Tchou, I; Pozzetto, B; Lucht, F; Desgranges, C; Genin, C
      Neutralization of human immunodeficiency virus type 1 (HIV-1) mediated by parotid IgA of HIV-1-infected patients

      JOURNAL OF INFECTIOUS DISEASES
    79. Holtkamp, N; Otteken, A; Findhammer, S; Miller, V; Kurth, R; Werner, A
      Unexpected coreceptor usage of primary human immunodeficiency virus type 1isolates from viremic patients under highly active antiretroviral therapy

      JOURNAL OF INFECTIOUS DISEASES
    80. Dejucq, N; Simmons, G; Clapham, PR
      T-cell line adaptation of human immunodeficiency virus type 1 strain SF162: effects on envelope, vpu and macrophage-tropism

      JOURNAL OF GENERAL VIROLOGY
    81. Blanco, J; Valenzuela, A; Herrera, C; Lluis, C; Hovanessian, AG; Franco, R
      The HIV-1 gp120 inhibits the binding of adenosine deaminase to CD26 by a mechanism modulated by CD4 and CXCR4 expression

      FEBS LETTERS
    82. Hovanessian, AG; Puvion-Dutilleul, F; Nisole, S; Svab, J; Perret, E; Deng, JS; Krust, B
      The cell-surface-expressed nucleolin is associated with the actin cytoskeleton

      EXPERIMENTAL CELL RESEARCH
    83. Cabezas, E; Wang, M; Parren, PWHI; Stanfield, RL; Satterthwait, AC
      A structure-based approach to a synthetic vaccine for HIV-1

      BIOCHEMISTRY
    84. Kirnarsky, L; Prakash, O; Vogen, SM; Nomoto, M; Hollingsworth, MA; Sherman, S
      Structural effects of O-glycosylation on a 15-residue peptide from the mucin (MUC1) core protein

      BIOCHEMISTRY
    85. Zhu, XG; Borchers, C; Bienstock, RJ; Tomer, KB
      Mass spectrometric characterization of the glycosylation pattern of HIV-gp120 expressed in CHO cells

      BIOCHEMISTRY
    86. Shen, WP; Proost, P; Li, BQ; Gong, WH; Le, YY; Sargeant, R; Murphy, PM; Van Damme, J; Wang, JM
      Activation of the chemotactic peptide receptor FPRL1 in monocytes phosphorylates the chemokine receptor CCR5 and attenuates cell responses to selected chemokines

      BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
    87. Zhou, W; Tomer, KB; Khaledi, MG
      Evaluation of the binding between potential anti-HIV DNA-based drugs and viral envelope glycoprotein gp120 by capillary electrophoresis with laser-induced fluorescence detection

      ANALYTICAL BIOCHEMISTRY
    88. Kuiken, C; Thakallapalli, R; Eskild, A; de Ronde, A
      Genetic analysis reveals epidemiologic patterns in the spread of human immunodeficiency virus

      AMERICAN JOURNAL OF EPIDEMIOLOGY
    89. Verrier, F; Moog, C; Barre-Sinoussi, F; Van der Ryst, E; Spenlehauer, C; Girard, M
      Immunisation with whole purified human immunodeficiency virus type 1 particles elicits enhancing antibodies in rhesus macaques

      BULLETIN DE L ACADEMIE NATIONALE DE MEDECINE
    90. Rubinstein, A; Mizrachi, Y; Pettoello-Mantovani, M; Lenz, J; Liu, GQ; Rubinstein, Y; Goldstein, H; Yust, I; Burke, M; Vardinon, N; Spirer, Z; Cryz, SJ
      Immunologic responses of HIV-1-infected study subjects to immunization with a mixture of peptide protein derivative-V3 loop peptide conjugates

      JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
    91. Louisirirotchanakul, S; Beddows, S; Cheingsong, R; Shaffer, N; Mastro, TD; Likanonsakul, S; Wasi, C; Taylor, GP; Weber, JN
      Role of maternal humoral immunity in vertical transmission of HIV-1 subtype E in Thailand

      JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES AND HUMAN RETROVIROLOGY
    92. Metlas, R; Trajkovic, D; Srdic, T; Veljkovic, V; Colombatti, A
      Anti-V3 and anti-IgG antibodies of healthy individuals share complementarity structures

      JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES AND HUMAN RETROVIROLOGY
    93. Moulard, M; Mabrouk, K; Martin, I; Van Rietschoten, J; Rochat, H; Sabatier, JM
      V-3 loop-derived peptide SPC3 inhibits infection of CD4- and galactosylceramide(-) cells by LAV-2/B

      JOURNAL OF PEPTIDE RESEARCH
    94. Jansson, M; Backstrom, E; Bjorndal, A; Holmberg, V; Rossi, P; Fenyo, EM; Popovic, M; Albert, J; Wigzell, H
      Coreceptor usage and RANTES sensitivity of non-syncytium-inducing HIV-1 isolates obtained from patients with AIDS

      JOURNAL OF HUMAN VIROLOGY
    95. Debnath, AK; Jiang, SB; Strick, N; Lin, K; Kahl, SB; Neurath, AR
      Anti-HIV-1 activity of carborane derivatives of porphyrins

      MEDICINAL CHEMISTRY RESEARCH
    96. Cano, CAD
      The multi-epitope polypeptide approach in HIV-1 vaccine development

      GENETIC ANALYSIS-BIOMOLECULAR ENGINEERING
    97. Bryder, K; Sbai, H; Nielsen, HV; Corbet, S; Nielsen, C; Whalen, RG; Fomsgaard, A
      Improved immunogenicity of HIV-1 epitopes in HBsAg chimeric DNA vaccine plasmids by structural mutations of HBsAg

      DNA AND CELL BIOLOGY
    98. Tugarinov, V; Levy, R; Dahan-Schokoroy, A; Anglister, J
      Letter to the Editor: Backbone and C-beta assignments of the anti-gp120 antibody Fv fragment complexed with an antigenic peptide

      JOURNAL OF BIOMOLECULAR NMR
    99. Achour, A; Harris, RA; Persson, K; Sundback, J; Sentman, CL; Schneider, G; Lindqvist, Y; Karre, K
      Murine class I major histocompatibility complex H-2D(d): expression, refolding and crystallization

      ACTA CRYSTALLOGRAPHICA SECTION D-BIOLOGICAL CRYSTALLOGRAPHY
    100. Frey, SE
      HIV vaccines

      INFECTIOUS DISEASE CLINICS OF NORTH AMERICA


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 16/01/21 alle ore 07:22:30